Peptide dual agonists of GIPR and GLP2R
Abstract:
Provided herewith are peptide dual agonists of at least the GIPR (glucose-dependent insulinotropic polypeptide receptor) and the GLP2R (glucagon-like peptide-2 receptor), and their use for treatment of bone disorders such as osteoporosis.
Public/Granted literature
Information query
Patent Agency Ranking
0/0